世界移植杂志(英文版)最新文献

{"title":"Changing landscape in living kidney donation in Greece.","authors":"Nikolaos Karydis,&nbsp;Ioannis Maroulis","doi":"10.5500/wjt.v13.i2.28","DOIUrl":"https://doi.org/10.5500/wjt.v13.i2.28","url":null,"abstract":"<p><p>Patients with end-stage renal disease in Greece are facing long waiting times to receive a kidney transplant from a deceased donor. Living kidney donation offers a valuable alternative that provides optimal outcomes and significantly expands the donor pool but still remains relatively underutilised. Developments around the world in the field of kidney transplantation mandate a change in current practice to include additional options for living donation through paired exchange, antibody-incompatible transplantation and other strategies, following careful consideration of the cultural and ethical factors involved in these complex clinical decisions. An increase in living donation rates may be achieved in several ways, including targeted campaigning to overcome potential barriers. Educating clinicians on transplantation will prove as equally important as informing patients and prospective donors but requires training and resources. Adoption of established practices and implementation of new strategies must be tailored to the needs of the Greek donor and recipient population. Local beliefs about donation, perception of associated risk and other social characteristics must be considered in the design of future strategies. Facilitating living donation in a safe environment with appropriate donor and recipient education will form the solid foundation of a new era of kidney transplantation in Greece.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"13 2","pages":"28-35"},"PeriodicalIF":0.0,"publicationDate":"2023-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/a4/WJT-13-28.PMC9993187.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9095017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Translational research and innovation in modern transplant practice: Paradigms from Greece and around the world.","authors":"Georgios Tsoulfas, Ioannis Boletis, Vassilios Papalois","doi":"10.5500/wjt.v13.i2.25","DOIUrl":"10.5500/wjt.v13.i2.25","url":null,"abstract":"<p><p>The continuous clinical and technological advances, together with the social, health and economic challenges that the global population faces, have created an environment where the evolution of the field of transplantation is essentially necessary. The goal of this special issue is to provide a picture of the current status of transplantation in Greece as well as in many other countries in Europe and around the world. Authors from Greece and several other countries provide us with valuable insight into their respective areas of transplant expertise, with a main focus on the field of translational research and innovation. The papers that are part of this Special Issue \"Translational Research and Innovation and the current status of Transplantation in Greece\" have presented innovative and meaningful approaches in modern transplant research and practice. They provide us with a clear overview of the current landscape in transplantation, including liver transplantation in the context of a major pandemic, the evolution of living donor kidney transplantation or the evolution of the effect of hepatitis C virus infection in transplantation, while at the same time explore more recent challen ges, such as the issue of frailty in the transplant candidate and the changes brought by newer treatments, such as immunotherapy, in transplant oncology. Additionally, they offer us a glimpse of the effect that technological innovations, such as virtual reality, can have on transplantation, both in terms of clinical and educational aspects. Just as critical is the fact that this Special Issue emphasizes the multidisciplinary, collaborative efforts currently taking place that link transplant research and innovation with other cutting-edge disciplines such as bioengineering, advanced information technology and artificial intelligence. In this Special Issue, in addition to the clinical and research evolution of the field of transplantation, we are witnessing the importance of interdisciplinary collaboration in medicine.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"13 2","pages":"25-27"},"PeriodicalIF":0.0,"publicationDate":"2023-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/1c/WJT-13-25.PMC9993189.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9453730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of total pancreatectomy with islet autotransplantation: A systematic review and meta-analysis.","authors":"Shrouq Khazaaleh,&nbsp;Sumbal Babar,&nbsp;Mohammad Alomari,&nbsp;Zaid Imam,&nbsp;Pravallika Chadalavada,&nbsp;Adalberto Jose Gonzalez,&nbsp;Bara El Kurdi","doi":"10.5500/wjt.v13.i1.10","DOIUrl":"https://doi.org/10.5500/wjt.v13.i1.10","url":null,"abstract":"<p><strong>Background: </strong>Despite the increased use of total pancreatectomy with islet autotransplantation (TPIAT), systematic evidence of its outcomes remains limited.</p><p><strong>Aim: </strong>To evaluate the outcomes of TPIAT.</p><p><strong>Methods: </strong>We searched PubMed, EMBASE, and Cochrane databases from inception through March 2019 for studies on TPIAT outcomes. Data were extracted and analyzed using comprehensive meta-analysis software. The random-effects model was used for all variables. Heterogeneity was assessed using the I² measure and Cochrane Q-statistic. Publication bias was assessed using Egger's test.</p><p><strong>Results: </strong>Twenty-one studies published between 1980 and 2017 examining 1011 patients were included. Eighteen studies were of adults, while three studied pediatric populations. Narcotic independence was achieved in 53.5% [95% Confidence Interval (CI): 45-62, <i>P</i> < 0.05, I² = 81%] of adults compared to 51.9% (95%CI: 17-85, <i>P</i> < 0.05, I² = 84%) of children. Insulin-independence post-procedure was achieved in 31.8% (95%CI: 26-38, <i>P</i> < 0.05, I² = 64%) of adults with considerable heterogeneity compared to 47.7% (95%CI: 20-77, <i>P</i> < 0.05, I² = 82%) in children. Glycated hemoglobin (HbA_1C) 12 mo post-surgery was reported in four studies with a pooled value of 6.76% (<i>P</i> = 0.27). Neither stratification by age of the studied population nor meta-regression analysis considering both the study publication date and the islet-cell-equivalent/kg weight explained the marked heterogeneity between studies.</p><p><strong>Conclusion: </strong>These results indicate acceptable success for TPIAT. Future studies should evaluate the discussed measures before and after surgery for comparison.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"13 1","pages":"10-24"},"PeriodicalIF":0.0,"publicationDate":"2023-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/8f/WJT-13-10.PMC9850868.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10638175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"COVID-19 in liver transplant patients: Impact and considerations.","authors":"Shrouq Khazaaleh, Mohammad Alomari, Sanskriti Sharma, Nikhil Kapila, Xaralambos Bobby Zervos, Adalberto Jose Gonzalez","doi":"10.5500/wjt.v13.i1.1","DOIUrl":"10.5500/wjt.v13.i1.1","url":null,"abstract":"<p><p>The coronavirus disease 2019 pandemic has significantly impacted liver tran splantation worldwide, leading to major effects on the transplant process, including the pretransplant, perioperative, and post-transplant periods. It is believed that patients with chronic liver disease, especially those with cirrhosis, have a higher risk of complications from coronavirus disease 2019 infection compared to the general population. However, evaluation of coronavirus disease 2019 effects on liver transplant patients has not uniformly demonstrated worse outcomes. Nonetheless, the pandemic created significant challenges and restrictions on transplant policies and organ allocation.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"13 1","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2023-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/7b/WJT-13-1.PMC9850867.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10583348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is the near coming xenotransplantation era relieving us from needing to look for more non-living organ donors?","authors":"Fernando M Gonzalez,&nbsp;Francisca Del Rocío Gonzalez","doi":"10.5500/wjt.v12.i12.388","DOIUrl":"https://doi.org/10.5500/wjt.v12.i12.388","url":null,"abstract":"<p><p>Despite organ transplantation being the most successful treatment for end-stage organ dysfunction, the number of annual solid organ transplantations is much lower than that required to satisfy the demand of patients on waiting lists. The explanation for this phenomenon is the relative scarcity of non-living organ donors due to several factors, such as: (1) Late arrival of patients with a neurocritical condition to an emergency service; (2) lack of detection of those patients as possible organ donors by health professionals dedicated to pro curement or by clinicians at emergency and intensive care units, for instance; (3) late transfer of the patient to an intensive care unit to try to recover their health and to provide hemodynamic, ventilatory, and metabolic support; (4) lack of confirmation of the physiological status of the possible donor; (5) late or incorrect positive diagnosis of the subject's death, either due to brain or cardiac death; (6) difficulty in obtaining legal authorization, either by direct relatives or by the authority, for the extraction of organs; and (7) deficient retrieval surgery of the organs actually donated. The recent reports of relatively successful xenotransplants from genetically modified pigs open the possibility to fix this mismatch between supply and demand, but some technical (organ rejection and opp ortunistic infections), and economic issues, still remain before accepting a progressive replacement of the organ sources for transplantation. An approximate economic cost analysis suggests that the hypothetical acquisition cost of any genetically modified pig derived organ is high and would not even satisfy the solid organ demand of the wealthiest countries.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 12","pages":"388-393"},"PeriodicalIF":0.0,"publicationDate":"2022-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/31/WJT-12-388.PMC9782685.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10439857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review of heart transplantation from hepatitis C-positive donors.","authors":"Palak Patel, Nirav Patel, Fahad Ahmed, Jason Gluck","doi":"10.5500/wjt.v12.i12.394","DOIUrl":"10.5500/wjt.v12.i12.394","url":null,"abstract":"<p><p>Significant scarcity of a donor pool exists for heart transplantation (HT) as the prevalence of patients with end-stage refractory heart failure is increasing exceptionally. With the discovery of effective direct-acting antiviral and favorable short-term outcomes following HT, the hearts from hepatitis C virus (HCV) patient are being utilized to increase the donor pool. Short-term outcomes with regards to graft function, coronary artery vasculopathy, and kidney and liver disease is comparable in HCV-negative recipients undergoing HT from HCV-positive donors compared to HCV-negative donors. A significant high incidence of donor-derived HCV transmission was observed with great success of achieving sustained viral response with the use of direct-acting antivirals. By accepting HCV-positive organs, the donor pool has expanded with younger donors, a shorter waitlist time, and a reduction in waitlist mortality. However, the long-term outcomes and impact of specific HCV genotypes remains to be seen. We reviewed the current literature on HT from HCV-positive donors.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 12","pages":"394-404"},"PeriodicalIF":0.0,"publicationDate":"2022-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/c8/WJT-12-394.PMC9782687.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10804799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current practice of live donor nephrectomy in Turkey.","authors":"Bakytbek Mankiev,&nbsp;Sanem Guler Cimen,&nbsp;Ismail Oskay Kaya,&nbsp;Sertac Cimen,&nbsp;Asir Eraslan","doi":"10.5500/wjt.v12.i12.405","DOIUrl":"https://doi.org/10.5500/wjt.v12.i12.405","url":null,"abstract":"<p><strong>Background: </strong>Over the last few years, the deceased donor organ donation rate was declined or remained stable, whereas the live donor organ donation rate has increased to compensate for the demand. Minimally invasive techniques for live donor nephrectomy (LDN) have also improved the live donor kidney donation rates. This increase has led to an interest in the surgical procedures used for LDN.</p><p><strong>Aim: </strong>To evaluate the LDN techniques performed in Turkey, the structure of surgical teams, and the training received. Additionally, the number of kidney transplantations at different centers, the surgeon experience level, differences in surgical approach during donor surgeries, and outcomes were assessed.</p><p><strong>Methods: </strong>A questionnaire was sent to the Turkish Ministry of Health-accredited transplant centers. It inquired of the number of LDN surgeries, surgical techniques, complications, optimization protocols, the experience of surgeons, and the training. Descriptive statistics were outlined as follows: Discrete numeric variables were expressed as medians (minimum-maximum), while categorical variables were shown as numbers and percentages. As a result of the goodness-of-fit tests, if the significance of the differences between the groups in discrete numerical variables for which the parametric test statistical assumptions were not met, data were analyzed with the Mann Whitney <i>U</i> test and the <i>χ</i> ² test.</p><p><strong>Results: </strong>The questionnaire was sent to 72 transplant centers, all of which replied. Five centers that reported not performing LDN procedures were excluded. Responses from the remaining 67 centers were analyzed. In 2019, the median number of kidney transplants performed was 45, and the median number of kidney transplants from living donors was 28 (1-238). Eleven (16.5%) centers performed 5-10, while 34 (50.7%) centers performed more than 100 live donor kidney transplants in 2019. While 19 (28.4%) centers performed the LDN procedures using the open technique, 48 (71.6%) centers implemented minimally invasive techniques. Among the centers preferring minimally invasive techniques for LDN, eight (16.6%) used more than one surgical technique. The most and the least common surgical techniques were transperitoneal laparoscopic (43 centers, 89.6%) and single port laparoscopic LDN (1 center, 2.1%) techniques, respectively. A positive association was found between the performance of minimally invasive techniques and the case volume of a transplant center, both in the total number and live donor kidney transplants (15 <i>vs</i> 55, <i>P</i> = 0.001 and 9 <i>vs</i> 42, <i>P</i> ≤ 0001 respectively). The most frequently reported complication was postoperative atelectasis (<i>n</i> = 33, 49.2%). There was no difference between the techniques concerning complications except for the chyle leak.</p><p><strong>Conclusion: </strong>Turkish transplant centers performed LDN surger","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 12","pages":"405-414"},"PeriodicalIF":0.0,"publicationDate":"2022-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/d8/WJT-12-405.PMC9782686.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10439861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Challenges in liver transplantation in the context of a major pandemic.","authors":"Eleni Theocharidou,&nbsp;Danielle Adebayo","doi":"10.5500/wjt.v12.i11.347","DOIUrl":"https://doi.org/10.5500/wjt.v12.i11.347","url":null,"abstract":"<p><p>Coronavirus disease-2019 (COVID-19) has led to a temporary suspension of liver transplant activity across the world and the remodeling of care for patients on the waiting list and transplant recipients with the increasing use of remote consultations. Emerging evidence shows that patients with more advanced liver disease are at increased risk of severe COVID-19 and death, whereas transplant recipients have similar risk with the general population which is mainly driven by age and metabolic comorbidities. Tacrolimus immunosuppression might have a protective role in the post-transplant population. Vaccines that have become rapidly available seem to be safe in liver patients, but the antibody response in transplant patients is likely suboptimal. Most transplant centers were gradually able to resume activity soon after the onset of the pandemic and after modifying their pathways to optimize safety for patients and workforce. Preliminary evidence regarding utilizing grafts from positive donors and/or transplanting recently recovered or infected recipients under certain circumstances is encou raging and may allow offering life-saving transplant to patients at the greatest need. This review summarizes the currently available data on liver trans plantation in the context of a major pandemic and discusses areas of uncertainty and future challenges. Lessons learnt from the COVID-19 pandemic might provide invaluable guidance for future pandemics.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 11","pages":"347-358"},"PeriodicalIF":0.0,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/69/WJT-12-347.PMC9693897.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40512815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Parvovirus B19 status in liver, kidney and pancreas transplant candidates: A single center experience.","authors":"Bojana Simunov,&nbsp;Anna Mrzljak,&nbsp;Zeljka Jurekovic,&nbsp;Snjezana Zidovec Lepej,&nbsp;Ana Bainrauch,&nbsp;Jadranka Pavicic Saric,&nbsp;Zeljka Hruskar,&nbsp;Leona Radmanic,&nbsp;Tatjana Vilibic-Cavlek","doi":"10.5500/wjt.v12.i11.378","DOIUrl":"https://doi.org/10.5500/wjt.v12.i11.378","url":null,"abstract":"<p><strong>Background: </strong>Parvovirus B19 (B19V) is associated with a wide range of clinical manifestations. The major presentation is erythema infectiosum. However, a persistent infection may cause pure red cell aplasia and chronic anemia in immunocompromized patients. The B19V seroprevalence varies with age and geographical location.</p><p><strong>Aim: </strong>To determine the B19V serological status and DNAemia in kidney, liver, and pancreas transplant candidates.</p><p><strong>Methods: </strong>Patients who underwent kidney, liver, or simultaneous kidney and pancreas/liver transplantation between January 2021 and May 2022 were included in the study. The serum samples were collected before transplantation. For detection of B19V DNA, a LightMix Kit B19V EC (TIB MOLBIOL, Berlin, Germany) was used. B19V IgM and IgG antibodies were detected using a commercial ELISA test (Euroimmun, Lübeck, Germany).</p><p><strong>Results: </strong>One hundred and thirty-one transplant candidates were included in the study, 71.0% male, with an average age of 53.27 years ± 12.71 years. There were 68.7% liver, 27.5% kidney, 3.0% simul taneous pancreas/kidney transplant (SPKT), and 0.8% simultaneous liver/kidney transplant recipients. No patients had detectable B19V DNA. B19V IgG seroprevalence was 77.1%. No acute or recent infections were detected (IgM antibodies). There was no difference in the mean age of seronegative and seropositive patients (51.8 years ± 12.9 years <i>vs</i> 53.7 years ± 12.7 years, <i>t</i> = -0.603; <i>P</i> = 0.548). Although seropositivity was lower in patients aged less than 30 years (66.6%) compared to the patients aged 30-59 years and > 60 years (80.4% and 78.1%, respectively), this difference was not significant. In addition, there was no difference in seropositivity between male and female transplant candidates, 76.3% and 78.9% (<i>χ</i> ² = 0.104; <i>P</i> = 0.748). The seroprevalence did not differ among organ recipients, with 77.8%, 80.6%, and 50.0% for liver, kidney, and SPKT, respectively, (<i>χ</i> ² = 5.297; <i>P</i> = 0.151). No significant difference was found in the seroprevalence in kidney transplant patients according to dialysis modality. Seroprevalence was 71.1% in hemodialysis patients, and 100% in peritoneal dialysis patients (<i>χ</i> ² = 0.799; <i>P</i> = 0.372).</p><p><strong>Conclusion: </strong>The B19V seroprevalence is expectedly high among kidney, liver, and pancreas transplant candidates, but there are still 22.9% of seronegative individuals who remain at risk for primary disease and severe manifestations. Further research should elucidate the necessity of B19V screening in peri-transplant management.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 11","pages":"378-387"},"PeriodicalIF":0.0,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/77/WJT-12-378.PMC9693899.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40512811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surgical chest complications after liver transplantation.","authors":"Apostolos C Agrafiotis,&nbsp;Konstantina-Eleni Karakasi,&nbsp;Mathilde Poras,&nbsp;Stavros Neiros,&nbsp;Stella Vasileiadou,&nbsp;Georgios Katsanos","doi":"10.5500/wjt.v12.i11.359","DOIUrl":"https://doi.org/10.5500/wjt.v12.i11.359","url":null,"abstract":"<p><p>Liver transplantation is a major abdominal operation and the intimate anatomic relation of the liver with the right hemidiaphragm predisposes the patient to various manifestations in the chest cavity. Furthermore, chronic liver disease affects pulmonary function before and after liver transplantation resulting in a considerable percentage of patients presenting with morbidity related to chest complications. This review aims to identify the potential chest complications of surgical interest during or after liver transplantation. Complications of surgical interest are defined as those conditions that necessitate an invasive procedure (such as thoracocentesis or a chest tube placement) in the chest or a surgical intervention performed by a thoracic surgeon. These complications will be classified as perioperative and postoperative; the latter will be categorized as early and late. Although thoracocentesis or a chest tube placement is usually sufficient when invasive measures are deemed necessary, in some patients, thoracic surgical interventions are warranted. A high index of suspicion is needed to recognize and treat these conditions promptly. A close collaboration between abdominal surgeons, intensive care unit physicians and thoracic surgeons is of paramount importance.</p>","PeriodicalId":68893,"journal":{"name":"世界移植杂志(英文版)","volume":"12 11","pages":"359-364"},"PeriodicalIF":0.0,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/6d/WJT-12-359.PMC9693896.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40512812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}